Digest Network Come funziona
Network
/
Società
No
Non verificato

NovaBay Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaOtticaSaluteVetrine/Shopping

17 comunicati stampa

Guarda tutti i comunicati
07/03/2025
Biotecnologia
Farmaceutica
Ottica
Salute
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/01/2025
Web e Social Network
Organizzazione Aziendale
Farmaceutica
Salute
Ottica
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
09/12/2024
Farmaceutica
Ottica
Salute
Sanità
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
15/11/2024
E-commerce
Pubblico Esercizio/Vendita al dettaglio
Salute
Sanità
Ottica
Biotecnologia
Industria
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/11/2024
Mercato azionario
Famiglia
Salute
Vetrine/Shopping
Farmaceutica
Ottica
Biotecnologia
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
06/11/2024
Organizzazione Aziendale
Mercato del lavoro
Biotecnologia
Pubblico Esercizio/Vendita al dettaglio
Vetrine/Shopping
Salute
Ottica
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
29/10/2024
Organizzazione Aziendale
Mercato del lavoro
Salute
Pubblico Esercizio/Vendita al dettaglio
Vetrine/Shopping
Sanità
Farmaceutica
Ottica
Biotecnologia
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/09/2024
Organizzazione Aziendale
Mercato del lavoro
Famiglia
Salute
Vetrine/Shopping
Ottica
Biotecnologia
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
13/08/2024
Famiglia
Salute
Vetrine/Shopping
Farmaceutica
Ottica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
01/08/2024
Farmaceutica
Ottica
Salute
Attrezzature medico-sanitarie
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
Fonte
NovaBay Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0